Cite
HARVARD Citation
Martínez-Cuadrón, D. et al. (2019). A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients. Leukemia research. pp. 1-10. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Martínez-Cuadrón, D. et al. (2019). A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients. Leukemia research. pp. 1-10. [Online].